Recent Updates
Recently added Catalysts
RMD Positive Sentiment Score: 70/100

Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025

Key Takeaway: Resmed has announced that it will release its financial and operational results for the fourth quarter of fiscal year 2025 on July 31, 2025. The results will be disclosed after market close, followed by a management-hosted webcast to discuss the findings and any relevant information. The earnings call will be accessible via a specific webcast link and will also be available for replay afterward on the company's investor relations website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Resmed plans to release fourth quarter results, showcasing transparency.
  • Management will discuss results, indicating openness to investor questions.
  • The company emphasizes innovative health technologies and commitment to improvement in patient health.

Full Press Release Details

SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2025 on Thursday, July 31, 2025, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
Location: https://investor.resmed.com
Date: Thursday, July 31, 2025
Time: 1:30 p.m. PDT / 4:30 p.m. EDT
International: London, Thursday, July 31, 2025, 9:30 p.m. BST Sydney, Friday, August 1, 2025, 6:30 a.m. AEST
Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on Resmed’s investor relations website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from July 31, 2025, until August 14, 2025, at:
U.S.: +1 877.660.6853
International: +1 201.612.7415
Conference ID: 13754703
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.
For investors For media
+1 858.836.5000 +1 619.510.1281
investorrelations@Resmed.com news@Resmed.com

Frequently Asked Questions

When will Resmed announce its Q4 fiscal year 2025 results?

Resmed will announce its Q4 results on July 31, 2025, after market close.

What time is Resmed's earnings webcast scheduled?

The earnings webcast is scheduled for 1:30 p.m. PDT on July 31, 2025.

Where can I access the Resmed earnings webcast?

The webcast can be accessed at https://investor.resmed.com.

When will a replay of the earnings webcast be available?

A replay will be available approximately two hours after the webcast.

How long is the phone replay of the Resmed earnings call available?

The phone replay will be available until August 14, 2025.

Last updated: Jul 1, 2025